
After private equity firms bought for-profit hospices, Medicare paid $993 more per hospice encounter and stays ran 6.3 days longer, with no increase in visits.
Patients are shouldering more of the healthcare cost burden than ever before. As a result, prices affect their decisions about healthcare.





